The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Drug Monitoring

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Drug Monitoring.
Andrzej Jakubowiak
Connection Strength
0.031
Drug Monitoring
  1. Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. Clin Cancer Res. 2016 Jan 01; 22(1):34-43.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.